138 results on '"Straughn, J.M."'
Search Results
2. Obstetric anal sphincter injury care bundle: a surgical quality improvement initiative
3. Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis
4. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
5. Inpatient chemotherapy for gynecologic cancer: When is it worth it?
6. Improving the surgical experience in gynecologic oncology patients with use of patient engagement technology: A prospective cohort study
7. Patient satisfaction of a restrictive opioid prescribing algorithm in gynecologic oncology patients undergoing surgery
8. Minimally invasive hysterectomy rates and surgical outcomes in uterine cancer: A Society of Gynecologic Oncology clinical outcomes registry analysis
9. Addressing the opioid epidemic in gynecologic oncology patients through a restrictive opioid prescribing practice
10. Risk factors for readmission among gynecologic oncology patients managed with an enhanced recovery after surgery protocol
11. The impact of code status simplification on end-of-life health care choices in gynecologic oncology
12. Enhanced recovery protocols decrease complication rates in all patients with a greater impact on the morbidly obese population
13. Prehabilitation is a cost-saving method with improved outcomes for medically frail patients undergoing surgery for epithelial ovarian cancer: A cost-effectiveness analysis
14. Compliance with a sepsis care pathway and its impact on morbidity and mortality in gynecologic oncology patients
15. Reducing short interval advanced imaging in gynecologic oncology patients presenting to the emergency department
16. A cost analysis of the impact of enhanced recovery after surgery (ERAS) protocol in gynecologic oncology surgery
17. Phase IB dose escalation and expansion trial of the oral hedgehog inhibitor sonidegib (LDE225) and weekly paclitaxel in platinum-resistant ovarian cancer (NCT02195973)
18. Impact of enhanced recovery after surgery (ERAS) protocol on postoperative pain control in chronic narcotic users
19. Evaluation of postoperative mortality in octogenarians with advanced epithelial ovarian cancer
20. Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis
21. Impact of enhanced recovery after surgery (ERAS) protocol on the gastrointestinal tract in gynecologic oncology patients undergoing laparotomy
22. Implementation of a genomic profiling program for gynecologic malignancies: An achievable clinical option
23. Using gene expression and DNA mutations to predict recurrence in high-intermediate risk endometrial cancer
24. Racial disparities in hereditary gynecologic cancer risk assessment: What and why?
25. Timing of robotic hysterectomy after cervical excisional procedure and associated perioperative complications
26. Inhibiting the wnt/β-catenin pathway modulates immune response in ovarian cancer
27. Inhibiting the wnt/β-catenin pathway modulates immune response in ovarian cancer
28. Hospital readmissions in gynecologic oncology patients: A target for quality improvement
29. Demographic and geographic factors associated with advanced cervical cancer in a rural state
30. Using value-based tools to determine the value of bevacizumab in cervical and ovarian cancer
31. Evaluation of major postoperative complications in gynecologic oncology patients undergoing bowel surgery: A quality improvement project
32. RNA expression patterns in human ascites-derived ovarian cancer cells allow molecular characterization and identification of potential therapeutic targets
33. Using DrugAbacus to determine the value of PD-1 inhibitors in ovarian cancer: How much should they cost?
34. Correlation between frozen section and final pathology in women with suspected gynecologic malignancies
35. Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
36. Augmenting the MHC II antigen-presentation pathway with epigenetic therapy in epithelial ovarian cancer
37. Quantitative and qualitative evaluation of pediatrician attitudes and barriers to HPV vaccination
38. The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis
39. Predictors of unplanned reoperation for ovarian cancer patients from the National Surgical Quality Improvement Program database
40. Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
41. Improved outcomes following the use of dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
42. Optimal according to whom? Interobserver variability in surgical cytoreduction for advanced ovarian carcinoma
43. Sentinel lymph node biopsy for patients with low-risk endometrial adenocarcinoma: A cost-effectiveness analysis
44. Early warning score: An indicator of adverse outcomes in postoperative patients on a gynecologic oncology service
45. Effective outpatient management of carboplatin hypersensitivity reactions in gynecologic oncology patients
46. The Society of Gynecologic Oncology Clinical Outcomes Registry: A single-institution experience
47. Are hospital readmissions an accurate measure of quality cancer care in gynecologic oncology patients?
48. What is the impact of distance from a comprehensive cancer center on survival in patients with cervical cancer?
49. Long-term safety follow-up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab
50. Departmental mortality review and present on admission indicator reporting improves observed-to-expected mortality ratios
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.